Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Schizophrenia or Psychotic Disorders
and you are
between 18 and 40
years old
The phase for this study is not defined.
Show me locations

The purpose

This study evaluates the role of the Nitric Oxide system in cognition in patients with schizophrenia. Participants will be randomised to 2 equal groups and receive either the Nitric Oxide donor molecule glyceryl trinitrate, or a placebo. Performance on several cognitive tasks will be assessed.

Provided treatments

  • Drug: Glyceryl Trinitrate
  • Drug: Placebo
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02906553. The sponsor of the trial is King's College London and it is looking for 36 volunteers for the current phase.
Official trial title:
The Role of Nitric Oxide in Cognition in Schizophrenia; The NOC Study (Nitric Oxide in Cognition)